Stockholm - Delayed Quote SEK
Scandinavian Real Heart AB (Publ) (HEART.ST)
13.50
-0.10
(-0.74%)
At close: 5:15:49 PM GMT+2
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Magnus Ohman | Executive Chairman of the Board | -- | -- | 1961 |
| Dr. Ina Laura Perkins | MD & CEO | -- | -- | -- |
| Dr. Azad Najar | Founder, Chief Innovation Officer, Head of Product Development & Innovation and Director | -- | -- | 1968 |
| Mr. Jimmy Nybom | Interim Chief Financial Officer | -- | -- | -- |
| Mr. Thomas Finocchiaro | Chief Technology Officer | -- | -- | 1976 |
| Dr. Ulf Kjellman | Chief Medical Officer & Member of Medical Advisory Board | -- | -- | -- |
Scandinavian Real Heart AB (Publ)
Kopparbergsvägen 6
Västerås, 722 13
Sweden
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 14
Description
Scandinavian Real Heart AB (Publ) engages in the design and development of an artificial heart. The company develops Realheart TAH to treat advanced stage heart failure. It also develops RealVAD for pulsating left ventricle assist; PulsePump, a pulsating flow for heart and lung machines; and Sternal Prosthesis to fix the sternum after open-chest surgery. The company was founded in 1999 and is based in Västerås, Sweden.
Corporate Governance
Scandinavian Real Heart AB (Publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available